Please use this identifier to cite or link to this item: http://repo.knmu.edu.ua/handle/123456789/27908
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLavrynenko, Olga-
dc.contributor.authorZemlianitsyna, Olha-
dc.contributor.authorDunaieva, Inna-
dc.contributor.authorKravchun, Nonna-
dc.contributor.authorSinaiko, Vadim-
dc.contributor.authorDefronzo, Ralph A.-
dc.date.accessioned2020-12-09T17:44:36Z-
dc.date.available2020-12-09T17:44:36Z-
dc.date.issued2020-01-
dc.identifier.citationRelationship between NAFLD and Cardiac Complications and Function in T2DM / О. Lavrynenko, O. Zemlianitsyna, I. Dunaeva, N. Kravchun, V. Sinaiko, R. Defronzo // Diabetes. – 2020. – N 69 (Supplement 1). – P. 405. – DOI: 10.2337/db20-405-P.en_US
dc.identifier.urihttps://repo.knmu.edu.ua/handle/123456789/27908-
dc.description.abstractLiver fibrosis in T2DM is associated with impaired cardiac function and increased cardiovascular complications. The results demonstrate that hepatic inflammation and fibrosis in T2DM patients with NAFLD is an important risk factor for cardiovascular disease and is associated with cardiac dysfunction.en_US
dc.language.isoenen_US
dc.subjectNAFLDen_US
dc.subjectCardiac complicationsen_US
dc.titleRelationship between NAFLD and Cardiac Complications and Function in T2DMen_US
dc.typeThesisen_US
Appears in Collections:Наукові праці. Кафедра клінічної фармакології та внутрішньої медицини



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.